CX 295
Alternative Names: AK 295; VasolexLatest Information Update: 13 Aug 1999
Price :
$50 *
At a glance
- Originator Cortex Pharmaceuticals
- Class Anti-ischaemics; Neuroprotectants
- Mechanism of Action Calpain inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebral vasospasm; CNS trauma; Stroke
Most Recent Events
- 13 Aug 1999 Discontinued-Preclinical for Cerebral vasospasm in USA (Unknown route)
- 13 Aug 1999 Discontinued-Preclinical for CNS trauma in USA (Unknown route)
- 13 Aug 1999 Discontinued-Preclinical for Stroke in USA (Unknown route)